This commentary article discusses the benefits of utilizing telemedicine to conduct shared medical appointments for people with type 1 diabetes and type 2 diabetes. We conducted a literature review of articles about shared medical appointments or group medical visits in people with diabetes with associated clinical data. We identified 43 articles. Models of this approach to care have demonstrated positive outcomes in adults and children with type 1 diabetes. Shared telemedicine appointments also have the potential to improve diabetes self-management, reduce the treatment burden, and improve psychosocial outcomes in adults with type 2 diabetes. Ten key recommendations for implementation are presented to guide the development of shared telemedicine appointments for diabetes. These recommendations can improve care for diabetes.
VoeltzDTönniesTBrinksR,et al.Future prevalence of type 2 diabetes—A comparative analysis of chronic disease projection methods. PLOS ONE2022; 17: e0264739.
3.
TönniesTBrinksRIsomS. Projections of Type 1 and Type 2 Diabetes Burden in the U.S. Population Aged <20 Years Through 2060: The SEARCH for Diabetes in Youth Study. Diabetes Care2023; 46(2): 313–320.
4.
KlonoffDC. The increasing incidence of diabetes in the 21st century. J Diabetes Sci Technol2009; 3: 1–2.
5.
ShubrookJHRamirezBFHealyAM, et al.Primary care diabetes fellowship programs: Developing national standards. Clin Diabetes2021; 39: 88–96.
6.
RobsonNHosseinzadehH. Impact of telehealth care among adults living with type 2 diabetes in primary care: A systematic review and meta-analysis of randomised controlled trials. Int J Environ Res Public Health2021; 18: 12171.
7.
CampionFDuffyLRojasR, et al.Trends in telemedicine Care for Diabetes During the COVID-19 Pandemic. telemedicine and Medicine Today. Published. Published online March 8, 2022, 2022. doi:10.30953/tmt.v7.311
8.
CzeislerMÉBarrettCESiegelKR, et al.Health care access and use among adults with diabetes during the COVID-19 pandemic - United States, February-March 2021. MMWR Morb Mortal Wkly Rep2021; 70: 1597–1602.
PeacockECraigLSKrousel-WoodM. Electronic health strategies to improve medication adherence in patients with cardiometabolic disease: Current status and future directions. Curr Opin Cardiol2022; 37: 307–316.
11.
ZhangAWangJWanX, et al.A meta-analysis of the effectiveness of telemedicine in glycemic management among patients with type 2 diabetes in primary care. Int J Environ Res Public Health2022; 19: 4173.
12.
AgastiyaIMCKuriantoEAkaliliH,et al.The impact of telehealth on self-management of patients with type 2 diabetes: A systematic review on interventional studies. Diabetes Metab Syndr2022; 16: 102485.
13.
NyenweEAAshbySTidwellJ. Diabetes consultation versus diabetes education in patients with poor glycaemic control: A telemedicine intervention study. J Telemed Telecare2022; 28: 687–693.
14.
KavehMHFaradonbehMRKavehS.Telehealth impact on biomedical, psychosocial, and behavioural outcomes in patients with diabetes older than 50 years: A systematic synthesis without meta-analysis. J Telemed Telecare. Published online November 18, 2021, 2021; 1357633X211052222. doi:10.1177/1357633X211052222
15.
UdsenFWHangaardSBenderC, et al.The effectiveness of telemedicine solutions in type 1 diabetes management: A systematic review and meta-analysis. J Diabetes Sci Technol2023; 17(3): 782–793.
16.
HangaardSLaursenSHAndersenJD, et al.The effectiveness of telemedicine solutions for the management of type 2 diabetes: A systematic review, meta-analysis, and meta-regression. J Diabetes Sci Technol2023;17(3):794–825.
17.
De GrootJWuDFlynnD, et al.Efficacy of telemedicine on glycaemic control in patients with type 2 diabetes: A meta-analysis. World J Diabetes2021; 12: 170–197.
18.
LeeSWHOoiLLaiYK. Telemedicine for the management of glycemic control and clinical outcomes of type 1 diabetes mellitus: A systematic review and meta-analysis of randomized controlled studies. Front Pharmacol2017; 8: 30.
19.
SuDZhouJKelleyMS, et al.Does telemedicine improve treatment outcomes for diabetes? A meta-analysis of results from 55 randomized controlled trials. Diabetes Res Clin Pract2016; 116: 136–148.
20.
SoodAWattsSAJohnsonJK, et al.Telemedicine consultation for patients with diabetes mellitus: A cluster randomised controlled trial. J Telemed Telecare2018; 24: 385–391.
21.
Flores GarciaJFayeEReidMW, et al.Greater telehealth use results in increased visit frequency and lower physician related-distress in adolescents and young adults with type 1 diabetes. J Diabetes Sci Technol2023; 17(4): 878–886.
22.
PoulsBPHVriezekolkJEBekkerCL, et al.Effect of interactive eHealth interventions on improving medication adherence in adults with long-term medication: Systematic review. J Med Internet Res2021; 23: e18901.
23.
SimRLeeSWH. Patient preference and satisfaction with the use of telemedicine for glycemic control in patients with type 2 diabetes: A review. Patient Prefer Adherence2021; 15: 283–298.
24.
ChoiNGDiNittoDMMartiCN,et al.Telehealth use among older adults during COVID-19: Associations with sociodemographic and health characteristics, technology device ownership, and technology learning. J Appl Gerontol2022; 41: 600–609.
25.
AgarwalSSimmondsIMyersAK. The use of diabetes technology to address inequity in health outcomes: Limitations and opportunities. Curr Diab Rep2022; 22: 275–281.
26.
PatelPDCobbJWrightD, et al.Rapid development of telehealth capabilities within pediatric patient portal infrastructure for COVID-19 care: Barriers, solutions, results. J Am Med Inform Assoc2020; 27: 1116–1120.
27.
KjærulffEMAndersenTHKingodN,et al.When people with chronic conditions turn to peers on social Media to obtain and share information: Systematic review of the implications for relationships with health care professionals. J Med Internet Res2023; 25: e41156.
28.
ParikhMRajendranID’AmicoS, et al.Characteristics and components of medical group visits for chronic health conditions: A systematic scoping review. J Altern Complement Med2019; 25: 683–698.
29.
JaberRBraksmajerATrillingJ. Group visits for chronic illness care: Models, benefits and challenges. Fam Pract Manag2006; 13: 37–40.
30.
BerwickDMNolanTWWhittingtonJ. The triple aim: Care, health, and cost. Health Aff (Millwood)2008; 27: 759–769.
CunninghamSDSutherlandRAYeeCW, et al.Group medical care: A systematic review of health service performance. Int J Environ Res Public Health2021; 18: 12726.
33.
RothIThompson-LastadAThomasAU. The quadruple aim as a framework for integrative group medical visits. J Altern Complement Med2020; 26: 261–264.
34.
Thompson-LastadAGardinerP. Group medical visits and clinician wellbeing. Glob Adv Health Med2020; 9: 2164956120973979.
35.
HousdenLWongSTDawesM. Effectiveness of group medical visits for improving diabetes care: A systematic review and meta-analysis. CMAJ2013; 185: E635–E644.
36.
HousdenLMWongST. Using group medical visits with those who have diabetes: Examining the evidence. Curr Diab Rep2016; 16: 34.
37.
RijswijkCZantingeESeesingF, et al.Shared and individual medical appointments for children and adolescents with type 1 diabetes; differences in topics discussed?Patient Educ Couns2010; 79: 351–355.
38.
KirkJKBoydCTSpanglerJG,et al.Group medical visits: Experiences with patient and resident implementation. Expert Rev Endocrinol Metab2020; 15: 51–57.
39.
GanetskyVSLongJAMitraN, et al.Impact of a multidisciplinary, endocrinologist-led shared medical appointment model on diabetes-related outcomes in an underserved population. Diabetes Spectr2020; 33: 74–81.
40.
HeislerMBurgessJCassJ, et al.Evaluating the effectiveness of diabetes shared medical appointments (SMAs) as implemented in five veterans affairs health systems: A multi-site cluster randomized pragmatic trial. J Gen Intern Med2021; 36: 1648–1655.
41.
BarnesPAStaabEMCampbellA, et al.Organizational factors influencing the early implementation process of diabetes group visits by five midwestern community health centers: A multisite case study analysis. Popul Health Manag2020; 23: 297–304.
42.
NoyaCECheslaCWatersC,et al.Shared medical appointments: An innovative model to reduce health disparities among latinxs with type-2 diabetes. West J Nurs Res2020; 42: 117–124.
43.
NoyaCAlkonACastilloE, et al.Shared medical appointments: An academic-community partnership to improve care among adults with type 2 diabetes in California Central Valley Region. Diabetes Educ2020; 46: 197–205.
44.
FloydBDBlockJMBuckinghamBB, et al.Stabilization of glycemic control and improved quality of life using a shared medical appointment model in adolescents with type 1 diabetes in suboptimal control. Pediatr Diabetes2017; 18: 204–212.
45.
PascualABPyleLNietoJ, et al.Novel, culturally sensitive, shared medical appointment model for Hispanic pediatric type 1 diabetes patients. Pediatr Diabetes2019; 20: 468–473.
46.
GoldHTPirragliaEHuangES, et al.Cost and healthcare utilization analysis of culturally sensitive, shared medical appointment model for Latino children with type 1 diabetes. Pediatr Diabetes2021; 22: 816–822.
47.
MajidiSReidMWFogelJ, et al.Psychosocial outcomes in young adolescents with type 1 diabetes participating in shared medical appointments. Pediatr Diabetes2021; 22: 787–795.
48.
McClainMRKlingensmithGJAndersonB, et al.Team clinic: Group approach to care of early adolescents with type 1 diabetes. Diabetes Spectr2018; 31: 273–278.
49.
WanWNathanAGReidMW, et al.The economic evaluation of team clinic-group approach to a care model of early adolescents with type 1 diabetes. J Pediatr Health Care2022; 36: 430–437.
50.
RaymondJK. Models of care for adolescents and young adults with type 1 diabetes in transition: Shared medical appointments and telemedicine. Pediatr Ann2017; 46: e193–e197.
NuñezDMarino-NuñezDStaabEM, et al.Adapting in-person diabetes group visits to a virtual setting across federally qualified health centers. Frontiers in Health Services2022; 2. https://www.frontiersin.org/articles/10.3389/frhs.2022.961073. Accessed January 6, 2023.
53.
KlonoffDCBlondeLCembrowskiG, et al.Consensus report: The current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes. J Diabetes Sci Technol2011; 5(6): 1529–1548.
54.
PatelTAJohnstonCACardenasVJ,et al.Utilizing telemedicine for group visit provider encounters: A feasibility and acceptability study. Int J Diabetes Metab Syndr2020; 1: 1–6.
55.
KlonoffDCWangJRodbardD, et al.A Glycemia Risk Index (GRI) of hypoglycemia and hyperglycemia for continuous glucose monitoring validated by clinician ratings. J Diabetes Sci Technol. Published online March 29, 2022, 2022; 19322968221085270. doi:10.1177/19322968221085273
56.
PeperEWilsonVMartinM, et al.Avoid Zoom Fatigue, Be Present and Learn. Published online March 2021.
XuNYNguyenKTDuBordAY, et al.The launch of the iCoDE standard project. J Diabetes Sci Technol2022; 16: 887–895.
59.
Nahum-ShaniISmithSNSpringBJ, et al.Just-in-time adaptive interventions (JITAIs) in mobile health: Key components and design principles for ongoing health behavior support. Ann Behav Med2018; 52: 446–462.
60.
GaoYDligachDMillerT, et al.Hierarchical Annotation for Building A Suite of Clinical Natural Language Processing Tasks: Progress Note Understanding. Published online April 6, 2022. 2022. doi:10.48550/arXiv.2204.03035
61.
Ben-AssuliO. Measuring the cost-effectiveness of using telehealth for diabetes management: A narrative review of methods and findings. Int J Med Inform2022; 163: 104764.
62.
SoCFChungJW. Telehealth for diabetes self-management in primary healthcare: A systematic review and meta-analysis. J Telemed Telecare2018; 24: 356–364.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
